Advertisement

Topics

Global Neuromodulation Market Analysis 2015 - Forecasts to 2020 for the $6.20 Billion Industry

20:00 EDT 19 Jul 2015 | Globe Newswire

Dublin, July 20, 2015 (GLOBE NEWSWIRE) -- Research and Markets (http://www.researchandmarkets.com/research/dqt6rk/neuromodulation) has announced the addition of the "Neuromodulation Market by Technology (Deep Brain Stimulation, Spinal Cord Stimulation, Transcranial Magnetic Stimulation) & by Application (Depression, Parkinson's, Tinnitus, Alzheimer's, Epilepsy, Ischemia, Obesity) Trends & Global Forecast to 2020" report to their offering.

The global neuromodulation market is expected to grow at a CAGR of 11.2% from 2015 to 2020, to reach $6.20 Billion by 2020 from $3.65 Billion in 2015. The market is dominated by North America, followed by Europe, Asia-Pacific, and rest of the world (RoW). Asia-Pacific is expected to grow at the highest CAGR during the forecast period.

Neuromodulation is a technique that acts directly on nerves or the target area, where the activity of nerves is altered. These alterations are due to the effects produced by electrical stimulation or drug infusion. These devices include small electrodes, which are placed in the brain, spinal cord, or peripheral nerves, and are connected via leads to an implantable pulse generator placed under the skin to generate electrical stimulation in a precise pattern.

The key factors that are expected to spur the growth of this market include rising geriatric population, increasing prevalence of neurological diseases, strong product pipeline offered by players, and expanded target applications and new indications. Moreover, expansion in emerging economies is likely to create significant growth opportunities for players operating in the market. However, factors such as unfavorable reimbursement scenario and lack of trained professionals are likely to pose as deterrents hampering market growth.

Scope

Technology

  • Deep Brain Stimulation
  • Spinal Cord Stimulation
  • Transcranial Magnetic Stimulation

Application

  • Depression
  • Parkinson's
  • Tinnitus
  • Alzheimer's
  • Epilepsy
  • Ischemia
  • Obesity

Key Topics Covered:

1 Introduction

2 Research Methodology

3 Executive Summary

4 Premium Insights

5 Market Overview

6 Global Neuromodulation Market, By Technology

7 Global Neuromodulation Market, By Application

8 Neuromodulation Market, By Region

9 Competitive Landscape

10 Company Profiles

- Boston Scientific Corporation
- Cyberonics, Inc.
- Medtronic, Inc.
- Nevro Corporation
- St Jude Medical, Inc.

For more information visit http://www.researchandmarkets.com/research/dqt6rk/neuromodulation





CONTACT: Research and Markets
         Laura Wood, Senior Manager
         press@researchandmarkets.com

         For E.S.T Office Hours Call 1-917-300-0470
         For U.S./CAN Toll Free Call 1-800-526-8630
         For GMT Office Hours Call +353-1-416-8900

         U.S. Fax: 646-607-1907
         Fax (outside U.S.): +353-1-481-1716

         Sector: Central Nervous System

Primary Logo

NEXT ARTICLE

More From BioPortfolio on "Global Neuromodulation Market Analysis 2015 - Forecasts to 2020 for the $6.20 Billion Industry"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Neurology - Central Nervous System (CNS)
Alzheimer's Disease Anesthesia Anxiety Disorders Autism Bipolar Disorders Dementia Epilepsy Multiple Sclerosis (MS) Neurology Pain Parkinson's Disease Sleep Disorders Neurology is the branch of me...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Spinal Cord Disorders
The spinal cord is a bundle of nerves that runs down the middle of the back which carry signals back and forth between the body and brain. It is protected by vertebrae, which are the bone disks that make up the spine. An accident that damages the verte...